Migraine
📧 Sign up to get email alerts when something new happens for Migraine.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-07-29Clinical Trial Update: Effectiveness of a Health Education Programme for Prevention of Chronic Migraine: A Randomized Clinical Trial [NA]
A completed randomized clinical trial evaluating the effectiveness of a health education program to prevent chronic migraine.
-
FDA approval · 2024-07-16FDA Approved: TOPIRAMATE — Original Application (Glenmark Pharmaceuticals Inc., USA)
FDA approves Glenmark's Original Application for Topiramate, a generic anticonvulsant. Topiramate is approved for certain seizure disorders …
-
CLINICAL_TRIALS research · 2024-07-16Clinical Trial Update: Study Using the ShiraTronics Migraine Therapy System [NA]
A clinical trial investigating the ShiraTronics Migraine Therapy System for chronic migraine and headache is currently recruiting.
-
CLINICAL_TRIALS other · 2024-07-16Clinical Trial Update: Comparative Effects of Theragun Percussion Therapy and Compression Therapy in The Patients With Migraine [NA]
Clinical trial update on a study comparing Theragun percussion therapy and compression therapy for migraine; recruitment is ongoing.
-
FDA label_change · 2024-07-15FDA Approved: DIVALPROEX SODIUM — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for divalproex sodium submitted by Sun Pharmaceutical Industries, Inc. The action pertains to labeli…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-07-15Clinical Trial Update: Valproate Versus Topiramate in Migraine [Phase 3]
A Phase 3 trial sponsored by Kafrelsheikh University comparing valproate to topiramate for migraine has completed (status COMPLETED).
-
CLINICAL_TRIALS research · 2024-07-12Clinical Trial Update: Comparison of the Effectiveness of First-line Preventive Treatment of Migraine in Primary Care [Phase 4]
An update on a Phase 4 clinical trial comparing first-line preventive treatments for migraine in primary care; the study is currently not ye…
-
FDA approval · 2024-07-11FDA Approved: PROPRANOLOL HYDROCHLORIDE — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental application for propranolol hydrochloride by Lannett Company, Inc., approving changes to the existing ANDA to su…
-
CLINICAL_TRIALS trial_result · 2024-07-03Clinical Trial Update: New-onset Severe Headache After Covid-19 Vaccine
A completed clinical trial update reports new-onset severe headaches following COVID-19 vaccination, indicating a potential safety signal th…
-
CLINICAL_TRIALS research · 2024-07-03Clinical Trial Update: Valproate Versus Propranolol in Migraine [Phase 4]
A Phase 4 clinical trial at Kafrelsheikh University is comparing valproate with propranolol for migraine disorders and is currently recruiti…
-
CLINICAL_TRIALS research · 2024-07-01Clinical Trial Update: Physiotherapy Intervention for Migraine Symptoms [Phase 3]
A Phase 3 clinical trial is evaluating a physiotherapy intervention to reduce migraine symptoms. Recruitment is ongoing.
-
CLINICAL_TRIALS withdrawal · 2024-07-01Clinical Trial Update: 4-Aminopyridine, Atenolol, or Placebo in Patients With Vestibular Migraine [Phase 2]
Phase 2 clinical trial evaluating 4-aminopyridine, atenolol, or placebo in vestibular migraine has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2024-06-26Clinical Trial Update: Chronic Postconcussive Headache: A Placebo-Controlled Treatment Trial of Prazosin [Phase 1, Phase 2]
This clinical trial update reports the completed Phase 1/2 evaluation of prazosin for chronic postconcussive headache, with results posted.
-
CLINICAL_TRIALS trial_result · 2024-06-18Clinical Trial Update: A Study of Galcanezumab (LY2951742) in Adult Participants With Episodic Migraine [Phase 4]
Phase 4 study of galcanezumab in adults with episodic migraine has completed, and results were posted on 2024-06-18.
-
CLINICAL_TRIALS research · 2024-06-18Clinical Trial Update: Repetitive Transcranial Magnetic Stimulation in Treatment and Prophylaxis of Chronic Migraine in Patients With no Prophylactic Treatment for the Last 3 Months [NA]
Sohag University is recruiting participants for a clinical trial evaluating repetitive transcranial magnetic stimulation for treatment and p…
-
FDA approval · 2024-06-14FDA Approved: CAFERGOT — Supplemental Application (Trifluent Pharma, LLC)
FDA approved a supplemental application for CAFERGOT, a migraine treatment containing ergotamine tartrate and caffeine, submitted by Triflue…
-
CLINICAL_TRIALS research · 2024-06-14Clinical Trial Update: Migraine Attack Pain Phase Prediction Study
A recruiting clinical trial evaluating a predictive model for migraine attack pain phases, sponsored by Fundación de Investigación Biomédica…
-
FDA approval · 2024-06-13FDA Approved: DIVALPROEX SODIUM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for divalproex sodium from Aurobindo Pharma Limited.
-
FDA approval · 2024-06-13FDA Approved: TOPIRAMATE — Original Application (Ascend Laboratories, LLC)
The FDA approved Ascend Laboratories' original application for a generic topiramate product.
-
CLINICAL_TRIALS trial_result · 2024-06-07Clinical Trial Update: Biomarker and Genetic Predictors of Erenumab Treatment Response [Phase 4]
Phase 4 trial evaluating biomarkers and genetic predictors of response to erenumab in migraine; results were posted in 2024.
-
FDA approval · 2024-06-05FDA Approved: SUMATRIPTAN — Supplemental Application (Cipla USA Inc.)
The FDA approved a supplemental application for Sumatriptan from Cipla USA Inc., supporting marketing of this generic migraine medication. T…
-
CLINICAL_TRIALS research · 2024-06-04Clinical Trial Update: Music and Imagery for Veterans With Migraine Headache [NA]
A clinical trial evaluating music and imagery for migraine in veterans is currently not yet recruiting. The sponsor is the Richard L. Roudeb…
-
CLINICAL_TRIALS trial_result · 2024-05-29Clinical Trial Update: Real World Effectiveness of Eptinezumab in Participants With Migraine [Phase 4]
Phase 4 real-world effectiveness study of eptinezumab for migraine; the trial was terminated and results were posted in May 2024.
-
CLINICAL_TRIALS trial_result · 2024-05-29Clinical Trial Update: MicroRNA Profile and Erenumab Treatment [NA]
A completed clinical trial update examining microRNA profiles in relation to erenumab treatment for migraine.
-
CLINICAL_TRIALS research · 2024-05-29Clinical Trial Update: Sensitivity to Acute Cerebral Ischemia in Migrainers
This clinical trial update describes a study on sensitivity to acute cerebral ischemia in migrainers, including ischemic stroke and migraine…